Sepsis is the leading cause of death in most intensive care units (Angus et al., 2001; Martin et al., 2003). Sepsis results from dysregulation of the normally protective anti-microbial host defense mechanism and represents a systemic inflammatory response that is associated with hypotension, insufficient tissue perfusion, uncontrolled bleeding, and multiple organ failure/dysfunction (Bone et al., 1992; Natanson et al., 1994). Accordingly, a major focus of sepsis research has been the development of anti-inflammatory strategies. In clinical trials, however, most of the therapies that may modify systemic inflammation have largely failed to reduce mortality in patients with severe sepsis (Zeni et al., 1997; Natanson et al., 1998; Marshall, 2000). These failed trials include administration of high-dose glucocorticoids; polyclonal and monoclonal antibodies against endotoxin and various inflammatory mediators such as tumor necrosis factor (TNF)-α; anti-inflammatories; nitric oxide (NO) inhibitors; anti-oxidants; and others. Hence, new understanding of the pathophysiological mechanisms underlying this complex disorder is needed to develop novel therapeutic strategies that will impact favorably on septic patient outcome.
Apoptosis is a second prominent feature of sepsis. This process is a mechanism of tightly regulated disassembly of cells caused by activation of certain specialized proteases called caspases. A number of laboratories have demonstrated that sepsis induces extensive lymphocyte apoptosis, which can impairment of immunoresponses, thereby predisposing patients to septic death (Ayala & Chaudry, 1996; Wesche et al., 2005; Hotchkiss et al., 2005; Lang & Matute-Bello, 2009; Matsuda et al., 2010a). Parenchymal cells, including intestinal and lung epithelial cells, also have increased apoptotic cell death in animal models of sepsis (Coopersmith et al., 2002a, 2002b; Perl et al., 2007). An autopsy study comparing samples from multiple organ systems in 20 patients who died of sepsis with those from 16 critically ill, non-septic patients has shown that gut epithelial apoptosis is increased in septic patients (Hotchkiss et al., 1999a). Moreover, it has been suggested that vascular endothelial cells may be undergoing apoptosis in sepsis (Hotchkiss et al., 2002). In sepsis, endothelial cell apoptosis may be associated with microvascular dysfunction with reduced perfusion and oxygen, which could result in tissue hypoxia and, ultimately, in the development of organ failure (Matsuda & Hattori, 2007). This could explain partly the disappointment in a large number of sepsis trials conducted with interventions against individual steps in the inflammatory cascade, leading investigators to the question of whether death in septic patients stems from uncontrolled inflammation (Hattori et al., 2010).
To reduce sepsis-induced apoptosis, caspase inhibitors have been examined in mice with cecal ligation and puncture (CLP)-induced sepsis. It has been reported that the pan-caspase inhibitor
Small interfering RNA (siRNA) is another potential reversible inhibitor of the apoptotic death pathways. siRNA therapy may offer a unique alternative sepsis treatment to shorten the apoptotic arm of sepsis, revealing a number of targets within the apoptotic death pathways, which may be useful in designing stand-alone and/or adjuvant therapies that would have a significant impact on septic mortality. Although the causative agents of sepsis vary widely as do their traditional anti-microbial treatments, siRNA therapy targeted toward salvaging immune effector cells, vascular endothelial cells, and parenchymal cells from apoptosis has the potential to be beneficial in sepsis regardless of the source. We have generated synthetic double-stranded siRNA targeting Fas-associated death domain (FADD) and examined the therapeutic effect of systemic administration of the siRNA in the CLP mouse model, regarded as a highly clinically relevant animal model of polymicrobial sepsis. As described below, FADD is an essential component of the death-inducing signaling complex (DISC) for all death receptors (Thorburn, 2004; Lavrik et al., 2005). Here we present that this RNA interference-mediated gene silencing
2. Apoptotic cell death pathways
Two major pathways are involved in the initiation of apoptotic cell death (Figure 1) (Roy & Nicholson, 2000). The first apoptotic pathway is mediated by specific ligands and surface receptors, which are capable of delivering a death signal from the microenvironment and can activate the execution of apoptosis in the cell cytoplasm and organelles
(Herr & Debatin, 2001). This pathway is termed the extrinsic pathway. The second apoptotic pathway called the intrinsic pathway is activated by mitochondrial injury (Korsmeyer, 1999). The two apoptotic signaling pathways ultimately converge into a common pathway causing the activation of effector enzymes termed caspases.
The extrinsic pathway involves activation of members of the TNF receptor (TNF-R) family with an intracellular death domain (DD), including TNF-R1, Fas, DR3, DR4, DR5, and DR6. These death receptors transmit apoptotic signals initiated by specific ligands such as TNF-α, Fas ligand (FasL), and TRAIL. Thus, once activated, death receptors recruit the adaptor molecule FADD (plus others in some cases) through the homophilic interaction of their own DD to the DD of the adaptor molecule. FADD can then recruit the apoptosis initiator enzyme procaspase-8 into the DISC as a consequence of the death effector domain-mediated homophilic interaction. Subsequently, procaspase-8 is activated proteolytically into caspase-8 and further activates the apoptosis effector enzymes caspase-3 and other execuitioner caspases (caspase-6 and caspase-7) (Thorburn, 2004; Lavrik et al., 2005; Green & Kroemer, 2005).
The intrinsic pathway is initiated by stress signals through the release of apoptogenic factors such as cytochrome
In certain types of cells, there is extensive cross-talk that occurs between the extrinsic and intrinsic apoptotic pathways (Roy & Nicholson, 2000). Thus, the extrinsic and intrinsic apoptotic pathways are intimately connected. This appears to occur via the proteolysis of BID, which normally serves an anti-apoptotic role within the intrinsic mitochondrial-mediated pathway. BID is truncated to receptor pathway, whereupon tBID promotes activation of Bax and Bak and thereby induces cytochrome
3. Impact of the FADD gene silencing with siRNA in sepsis therapy
3.1. Sepsis-induced up-regulation of death receptors
We initially verified the hypothesis that tissue expression of death receptors is up-regulated in sepsis. Polymicrobial sepsis was induced by CLP in BALB/c mice (Matsuda et al., 2005). A middle abdominal incision was performed under anesthesia. The cecum was mobilized, ligated at 5 mm from its top, and then perforated in two locations with a 21-gauge needle, allowing expression of feces. The bowel was repositioned, and the abdomen was closed. Sham-operated animals underwent the same procedure except for ligation and puncture of the cecum. This model has high clinical relevance to humans, because it reproduces many hallmarks of sepsis that occur in patients (Hubbard et al., 2005).
Immunoblot analysis showed that surface expression of the two death receptors TNF-R1 and Fas were up-regulated in lung tissues with time after CLP induction of sepsis (Figure 2A). Immunohistochemical studies indicated more abundant TNF-R1 expression in the inner wall of microvessels from septic mouse lungs (Figure 2B). Meanwhile, Fas was detected mainly in alveolar epithelial Type II cells (Matsuda et al., 2009). Similar to these death receptors, DR4 and DR5, both of which mediate TRAIL-induced cell death, were up-regulated in septic mouse lungs (Matsuda et al., 2009). We also found time-dependent increases in surface expression of TNF-R1 and Fas in mouse aortic tissues after CLP sepsis (Figure 3A). These death receptors are likely to be up-regulated mainly on endothelial cells, because the sepsis-induced up-regulation of TNF-R1 and Fas expression in aortic tissues was abolished when the tissues were denuded mechanically. Previous works from other laboratory have demonstrated that Fas expression is increased in hepatocytes and in selected gastrointestinal-associated lymphoid tissues (Chung et al., 2001, 2003). Moreover, splenocytes harvested 24 hours after CLP and stimulated with the T cell mitogen concavalin A showed an increase in CD4+ T-cell apoptosis as compared to sham controls, which was associated with an increase in Fas expression (Ayala et al., 1999). Based on the findings of
increased death receptor expression in tissues of septic mice, we suggest the importance of the extrinsic death receptor pathway in apoptotic cell death in sepsis, although a preeminent role for the intrinsic mitochondrial pathway has often been noted (Exline & Crouser, 2008).
As presented in Figure 1, death receptors, after ligand binding, recruit the adaptor protein FADD through hemophilic interaction of their DD with the DD of FADD, and then FADD can recruit procaspase-8 to the DISC, thereby causing its activation (Thorburn, 2004; Lavrik et al., 2005). When FADD protein levels were assessed by Western blotting, induction of sepsis by CLP led to a time-dependent increase in FADD protein expression in aortic tissues (Figure 3B). This increase occurred on endothelial cells since FADD protein expression was not increased in endothelium-denuded aortic tissues from septic animals. For silencing of gene expression of FADD, siRNA oligonucleotides with the following sense and antisense sequences were designed: 5’-GCA GUC UUA UUC CUA Att-3’ and 5’-UUA GGA AUA AGA GGA GUA Ctt-3’ (Matsuda et al., 2009, 2010b). In vivo transfection of synthetic siRNAs via tail vein was performed at 10 hours after CLP with Lipofectamine RNAiMAX (Invitrogen). We used Opti-MEM I Reduced Serum Medium (Invitrogen) to dilute siRNAs and Lipofectamine RNAiMAX before complexing, by which 50 μg of FADD siRNA sequence was usually delivered. Systemic delivery of FADD siRNA nearly completely eliminated aortic protein expression of FADD (Figure 3B). We also confirmed that the increased levels of FADD mRNA and protein in lungs after CLP induction of sepsis were strongly suppressed by systemic application of FADD siRNA but not of scrambled siRNA (Matsuda et al., 2009). These findings suggested the successful efficacy of systemically administered siRNA for silencing tissue expression of FADD in septic mice.
3.2. Effect of FADD siRNA on cell apoptosis in sepsis
To assess whether FADD siRNA treatment has a beneficial effect on sepsis-induced apoptotic cell death in lungs, the tissue sections were labeled with an
Physiologic TUNEL-positive cells, morphologically identical to lymphocytes (Matsuda et al., 2009, 2010a), were sporadically present in the spleen tissues from sham control mice (Figure 4B). In spleens 24 hours after septic insult, marked apoptosis of follicular lymphocytes were observed. Most apoptotic lymphocytes were located in the white pulp of the spleen. TUNEL-positive lymphocytes in spleen follicles were greatly reduced when FADD siRNA was systemically given after CLP. Administration of scrambled siRNA to septic mice showed more frequent TUNEL positivity than no treatment.
Light microscopic studies of aortic tissue sections from septic mice at 24 hours after CLP showed partial detachment of endothelial cells from the basal membrane (Matsuda et al., 2007, 2010b). When the tissue sections were labeled with an
3.3. Effect of FADD siRNA on sepsis-induced autophagy in endothelial cells
A non-apoptotic and non-oncotic type of cell death has been recognized (Clarke, 1990). This type of cell death is characterized by the appearance of double- or multi-membrane cytoplasmic vesicles engulfing bulk cytoplasm and cytoplasmic organelles, such as mitochondria and endoplasmic reticulum, and their delivery to and subsequent degradation by the lysosomal system of the same cell (Gozuacik & Kimchi, 2004). This type of cell death is referred to as autophagic cell death, but it is still unsettled whether autophagy is the direct primary cause of cell death or a compensatory mechanism that tries to rescue a cell from dying. In starvation, autophagy provides an internal source of nutrients for energy generation, promoting cell survival. Defects in autophagy have been implicated in the pathophysiology of cancer and neurodegenerative diseases (Rabinowitz & White, 2010). On the other hand, systemic inflammatory response syndrome and multiple organ dysfunction syndrome are suggested to be accompanied by increased cell death, including autophagy, in the affected organs (Yasuhara et al., 2007). A recent report has shown that LPS induces autophagy in human umbilical vein endothelial cells (Meng
Our ultrastructural analysis using transmission electron microscopy indicated the formation of autophagy-like vesicles in aortic endothelial cells of CLP septic mice (Figure 5B). Microtubule-associated protein 1A/1B-light chain 3 (LC3) is a soluble protein with a molecular mass of ~17 kDa that is distributed ubiquitously in mammalian tissues. Cleavage of LC3 at the carboxyterminus immediately following synthesis yields the cytosolic LC3-I form. LC3-I form is converted to LC3-II during autophagy. Thus, LC3-II is widely used as an indicator of autophagy (Kabaya et al., 2000). Western blot analysis revealed significantly elevated aortic LC3-II levels in the CLP septic group (Figure 6). Very interestingly, these autophagy-related changes were prevented by systemic application of FADD siRNA (Figures 5B and 6).
There are several lines of experimental evidence that apoptosis and autophagy may be interconnected in some settings, and in some cases even simultaneously regulated by the same trigger resulting in different cellular outcomes (Gozuacik & Kimchi, 2004). Previous data supporting the interconnection between the two types of cell death have come from gene expression profiles during steroid-triggered developmental cell death in the
3.4. Effect of FADD siRNA on animal survival after CLP
To evaluate the impact of FADD siRNA on survival benefit in sepsis, we examined mortality in mice subjected to CLP (Figure 7). After CLP, mice exhibited signs of sepsis. Thus, they showed lack of interest in their environment, displayed piloerection, and had crusty exudates around their eyes. Finally, all animals subjected to CLP without treatment died within 2 days. Treatment of CLP mice with scrambled siRNA was without effect on survival. However, when FADD siRNA was administered to CLP mice, its survival advantage was very striking (
Despite recent advances in antibiotics and critical care therapy, sepsis treatment remains clinical conundrum, and its prognosis is still poor, especially when septic shock and/or multiple organ failure develop. Although a host of promising candidates for therapeutic intervention in sepsis have been propelled, almost all of these trials have failed to demonstrate a mortality benefit for patients suffering from sepsis. Ongoing research into this highly lethal disorder has shown that apoptosis is fully associated with an unfavorable outcome of sepsis and its inhibition may provide useful therapies for treatment of sepsis. Here we propose that FADD siRNA therapy may offer a unique alternative sepsis treatment to shorten the apoptotic arm of sepsis. This therapy salvaged immune effector cells, vascular endothelial cells, and parenchyma cells from apoptosis, which would arrest the development of complications arising from sepsis, including multiple organ failure, and ultimately have a beneficial impact on septic mortality. While appreciating that additional work is required to optimize preclinical and possibly clinical application, treatment with FADD siRNA will hopefully provide novel potential usefulness for gene therapy that could improve the survival of critically ill septic patients.
We thank Mieko Watanabe for her excellent secretarial assistance. We are grateful to Kengo Tomita for his expert help in creating the figures in this article. This work was supported by a Grant-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology of Japan (18590233, 20590250) and by the Tamura Science Technology Foundation.